| Lars M. B. Lancaster | |
|---|---|
| Photo placeholder | |
| Affiliations | MRC Laboratory of Molecular Biology, Cambridge University of Cambridge |
| Country | United Kingdom |
| H-index | 160 |
| Research Focus | Tau, Cryo-EM, Protein Structure, Neurodegeneration |
| Mechanisms | Tau filaments, Cryo-electron microscopy, Filament structures, Protein aggregation |
Lars M. B. Lancaster is a distinguished structural biologist at the MRC Laboratory of Molecular Biology (LMB) in Cambridge, United Kingdom. With an h-index of 160, Dr. Lancaster has made groundbreaking contributions to our understanding of neurodegenerative diseases through his pioneering work using cryo-electron microscopy (cryo-EM) to determine the atomic structures of tau filaments in Alzheimer's disease and related disorders.
Dr. Lancaster's work represents a paradigm shift in neurodegeneration research, moving from descriptive pathology to atomic-level understanding of protein aggregation mechanisms. His discoveries have provided the structural foundation for understanding how tau protein misfolds and forms the filamentous inclusions characteristic of multiple neurodegenerative diseases.
Dr. Lancaster's groundbreaking structural studies have revolutionized our understanding of tau pathology:
His landmark 2017 paper published in Nature determined the first atomic structure of tau filaments from AD- The brain, revealing:
detailed fold of paired helical filaments (PHFs) and straight filaments (SFs)
Dr. Lancaster's work established the structural basis for classifying tauopathies:
Dr. Lancaster has pioneered the application of cutting-edge structural techniques:
Dr. Lancaster has authored numerous high-impact publications. Some of his most influential works include:
Dr. Lancaster's structural studies have illuminated key mechanisms in neurodegeneration:
Dr. Lancaster maintains active collaborations with leading researchers:
As a group leader at MRC LMB, Dr. Lancaster has trained numerous researchers in cryo-EM techniques who have gone on to apply these methods to other neurodegenerative disease proteins.
Dr. Lancaster's work has been recognized with numerous awards, including recognition for transforming our understanding of neurodegenerative disease pathology through structural biology.